Structure–Activity Relationship of Ionizable Lipids for siRNA and mRNA Lipid Nanoparticle Design
- 11 July 2025
- journal article
- Published by American Chemical Society (ACS) in ACS Biomaterials Science & Engineering
- Vol. 11 (8) , 4844-4852
Abstract
Lipid nanoparticles (LNPs) represent the most effective vehicle class identified to date for delivering RNA. A stronger understanding of the structure-activity relationships that govern successful mRNA delivery would enable the development of improved LNPs. Herein, ionizable lipids with high mRNA in vitro delivery efficacy among 465 lipids were selected to be evaluated for their in vivo activity and structure-activity relationship. Variations of these ionizable amino hydroxy and amino lipid families were synthesized, and 42 lipids were evaluated to study how chemical alterations of the carbon chain within the core influence LNP potency. To further understand the relationship between chemical structure and in vivo hepatic delivery potency, physicochemical properties including size, PDI, pKa, and buffering capacity were measured. Our evaluations revealed that both the pKa and buffering capacity may be valuable in predicting in vivo hepatic delivery based on lipid structures, expanding the range of acceptable LNP pKa to 6.2-7.4, and showed that the buffering capacity may help predict formulations for successful hepatic delivery of mRNA-LNPs. This study reiterates the importance of the chemical structure of the ionizable amino lipid for LNPs and highlights the intricacies of its relationship with the physical properties of LNPs. We anticipate that understanding the structure-activity relationship of ionizable lipids will be valuable for the continued rational design of ionizable amino lipids for the LNP delivery of small and large RNA cargoes.Keywords
Funding Information
- National Cancer Institute (CA269787-01, P30CA142543)
- Welch Foundation (I-2123-20220031)
- National Institute of Biomedical Imaging and Bioengineering (5R01EB025192-06)
This publication has 30 references indexed in Scilit:
- The role of lipid components in lipid nanoparticles for vaccines and gene therapyAdvanced Drug Delivery Reviews, 2022
- Discovery of a Novel Amino Lipid That Improves Lipid Nanoparticle Performance through Specific Interactions with mRNAAdvanced Functional Materials, 2021
- What does the success of mRNA vaccines tell us about the future of biological therapeutics?Cell Systems, 2021
- Self-assembled mRNA vaccinesAdvanced Drug Delivery Reviews, 2021
- The Biomolecular Corona of Lipid Nanoparticles for Gene TherapyBioconjugate Chemistry, 2020
- Branched‐Tail Lipid Nanoparticles Potently Deliver mRNA In Vivo due to Enhanced Ionization at Endosomal pHSmall, 2019
- Dendrimer‐Based Lipid Nanoparticles Deliver Therapeutic FAH mRNA to Normalize Liver Function and Extend Survival in a Mouse Model of Hepatorenal Tyrosinemia Type IAdvanced Materials, 2018
- A Novel Amino Lipid Series for mRNA Delivery: Improved Endosomal Escape and Sustained Pharmacology and Safety in Non-human PrimatesMolecular Therapy, 2018
- Lipid Nanoparticles for Short Interfering RNA Delivery2014
- Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo**Angewandte Chemie International Edition, 2012